TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biobasiq Sverige AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
17,734
|
12,064
|
11,697 |
Financial expenses |
30
|
39
|
57 |
Earnings before taxes |
49
|
708
|
1,281 |
EBITDA |
44
|
747
|
1,338 |
Total assets |
5,307
|
4,917
|
4,374 |
Current assets |
5,307
|
4,917
|
4,374 |
Current liabilities |
1,712
|
1,377
|
1,132 |
Equity capital |
3,595
|
3,540
|
3,242 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
67.7%
|
72.0%
|
74.1% |
Turnover per employee |
8,867
|
6,032
|
5,848 |
Profit as a percentage of turnover |
0.3%
|
5.9%
|
11.0% |
Return on assets (ROA) |
1.5%
|
15.2%
|
30.6% |
Current ratio |
310.0%
|
357.1%
|
386.4% |
Return on equity (ROE) |
1.4%
|
20.0%
|
39.5% |
Change turnover |
5,607
|
1,314
|
1,278 |
Change turnover % |
46%
|
12%
![]() |
12% |
Chg. No. of employees |
0
![]() |
0
|
-1 |
Chg. No. of employees % |
0%
![]() |
0%
|
-33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.